Signet Financial Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Buy |
10,917
+22
| +0.2% | +$6.32K | 0.39% | 82 |
|
|
2025
Q1 | $3.36M | Buy |
10,895
+79
| +0.7% | +$24.4K | 0.45% | 74 |
|
|
2024
Q4 | $3.82M | Buy |
10,816
+103
| +1% | +$36.3K | 0.49% | 65 |
|
|
2024
Q3 | $3.84M | Buy |
10,713
+413
| +4% | +$148K | 0.49% | 64 |
|
|
2024
Q2 | $3.28M | Buy |
+10,300
| New | +$3.28M | 0.44% | 74 |
|
|
2018
Q4 | – | Sell |
-35,877
| Closed | -$4.59M | – | 781 |
|
|
2018
Q3 | $4.59M | Sell |
35,877
-1,296
| -3% | -$166K | 0.8% | 41 |
|
|
2018
Q2 | $4.21M | Sell |
37,173
-1,043
| -3% | -$118K | 0.74% | 53 |
|
|
2018
Q1 | $4.29M | Buy |
+38,216
| New | +$4.29M | 0.77% | 52 |
|